Novaestiq
Offering a diverse range of aesthetic products for practices and consumers.
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
* | N/A | Acquisition | |
| Total Funding | 000k | ||
Founded in 2021, Novaestiq is a growth-oriented company operating in the aesthetic and medical dermatological sector. The company was established by Humberto Antunes, a partner at Gore Range Capital and the former global CEO of Galderma, alongside Miles Harrison, who previously served as the North American President at Galderma. Their shared background in the dermatology and aesthetics industry underpins the company's mission to introduce advanced technology to the North American aesthetic market.
Novaestiq focuses on providing a range of products and services to dermatologists and aesthetic practitioners, targeting the cash-pay aesthetics market. The business model is centered on B2B sales to medical practices, offering solutions that aim to support practice success and improve patient outcomes rather than employing aggressive sales tactics. In July 2025, the company was acquired by Waldencast, a global beauty and wellness platform, a strategic move intended to expand the offerings of its Obagi Medical brand into the U.S. dermal filler market. This acquisition effectively doubled Obagi Medical's addressable market by combining medical-grade skincare with in-office injectable procedures.
The company's product portfolio is diverse, featuring treatments for common skin concerns. Key offerings include the Saypha® line of hyaluronic acid (HA) dermal fillers, which it distributes in the U.S. through an agreement with Croma-Pharma GmbH. The Saypha® line utilizes a proprietary technology with an advanced 3D matrix for natural-looking results. Other products include Sebacia AcneIQ, which uses gold microparticles and lasers to address acne, and Epilacia, a light-based hair removal product. The company has multiple products that are FDA-cleared or pending FDA submission, including injectable HA gels like Saypha® ChIQ™ and MagIQ™. These products are now being integrated under the Obagi Medical brand to create a holistic skincare and aesthetic treatment system.
Keywords: aesthetic dermatology, medical dermatology, dermal fillers, hyaluronic acid fillers, skin health, aesthetic practitioners, practice success, Humberto Antunes, Miles Harrison, Waldencast, Obagi Medical, Croma-Pharma, Saypha, Sebacia AcneIQ, Epilacia, aesthetic solutions, skincare innovation, non-surgical aesthetics, cosmetic treatments, injectables